News & Announcements

The school's second annual PSR Symposium brought together postdocs, specialists, and researchers for a day of scientific presentations, career discussion, and recognition hosted by the Center for Collaborative Innovation.

Recently published findings reveal how the hypoxic, or low-oxygen, environment characteristic of pancreatic cancer reshapes the proteolytic landscape of the tumor, a discovery that could translate into better diagnostic tools or treatments.

The Department of Bioengineering and Therapeutic Sciences chair was honored for pioneering advances in room-temperature X-ray data collection techniques and ensemble modeling methods, which have enabled deeper understanding and engineering of proteins. He has also been a champion of collaborative, project-based learning and has advocated for greater accessibility in scientific publishing. 

Serendipitous teamwork between Department of Pharmaceutical Chemistry Professors and lab partners Steven Altschuler, PhD, and Lani Wu, PhD, and Catherine Lomen-Hoerth, MD, PhD, director of the ALS Center at UCSF, is developing a new approach to classifying and treating the complex neurodegenerative disease.

Powerful drug candidates perform better than Paxlovid against SARS-CoV-2 and could head off future coronavirus pandemics. The research, from a team at UCSF and Gladstone Institutes that includes School of Pharmacy researchers, has stalled since the grant was cut.

We asked the Department of Pharmaceutical Chemistry associate professor how helping to uncover the fundamental principles of our smell perception could improve understanding of how other proteins in the body recognize small molecules, including potential new drugs.

Eleven innovative projects with the potential to further the mission of the UCSF School of Pharmacy in new ways will garner a financial boost from the 2025 Mary Anne Koda-Kimble Seed Award for Innovation.

The QBI Coronavirus Research Group (QCRG) fast-tracked antiviral drug discovery by partnering with scientists around the globe and around the clock, deepening understanding of how viruses attack cells and shaping the future of pandemic preparedness.

UCSF School of Pharmacy experts share their perspectives on the lessons learned from the pandemic and the evolving role of pharmacy in strengthening public health, advancing scientific discovery and preparing for future global challenges.

A new therapy combines a drug to mark cancer cells for destruction and a radioactive antibody to kill them, while calculating an extremely safe dose of radiation that uses only the amount of radiation needed to beat the cancer.

Emily A. Hammad Mrig, PhD, is using natural language processing (NLP) to identify patients and solutions that make molecular diagnostics more affordable and equitable.

The recognition of Krogan, Shoichet, Manglik, and Giacomini underscores the school’s commitment to fostering groundbreaking research that addresses critical issues in health care and pharmaceutical sciences.

Department of Pharmaceutical Chemistry faculty member Aashish Manglik, MD, PhD, was celebrated as a curiosity-driven scientist in the 29th annual Byers Award Lecture, where he shared how he fulfilled a research dream in his journey from Stanford University to UCSF.

David Morris, MD, has worked with many Bay Area startups, including a spin-off from the lab of Department of Pharmaceutical Chemistry faculty member Jim Wells, PhD.

Department of Pharmaceutical Chemistry faculty members Brian Shoichet, PhD, and Jason Sello, PhD, combine collaboration, curiosity, and innovation to discover molecules that can become anesthetics administered without specialized training.

Charles Hart, PhD, director of the Catalyst Program, joins Department of Pharmaceutical Chemistry Chair Michelle Arkin in the center’s ongoing collaboration with academics, government labs, and pharmaceutical companies to develop drug leads that address unmet medical needs.

x 

Three students with ties to the School were finalists in the event, which challenges graduate students to explain their research to an audience of non-experts in just three minutes.

School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.

The 2024 Bowes Biomedical Investigator has been named, set to explore new scientific directions such as the intersection of GPCR research and neuropsychiatric diseases.